疫苗与众不同:疫苗预算影响分析的系统综述
该系统综述依据CRD指南检索多个数据库,分析已发表的疫苗预算影响分析(BIA)的方法学,共纳入22项研究。最常评估的疫苗为肺炎球菌(41%)、流感(23%)和轮状病毒(18%)。仅36%报告BIA计算过程,55%(n=12)报告了清单中不足50%的条目,方法学步骤报告不理想,难以评估结果有效性。
要点
- 纳入22项疫苗BIA研究,肺炎球菌疫苗占41%、流感疫苗占23%、轮状病毒疫苗占18%。
- 21项(95%)说明目标人群,20项(91%)明确研究视角,但仅36%报告BIA计算过程。
- 55%(n=12)的研究报告了清单中不足50%的推荐条目,方法学报告不理想。
核心结论
- 疫苗BIA的产出自2009年起增加,但方法学步骤的报告不理想,导致难以评估所呈现结果的有效性。
- 应在疫苗BIA国际指南中讨论疫苗特定问题,以提高研究质量。
研究设计与样本
- 系统综述,依据Centre for Reviews and Dissemination(CRD)指南检索MedLine、Embase、BVS、Cochrane Library、DARE、NHS EED、HTA Database及灰色文献。
- 由两名研究者独立筛选研究并提取数据,采用ISPOR 2012 Budget Impact Analysis Good Practice II Task Force评估方法学质量,进行定性叙述性综合。
- 共纳入22项已发表的疫苗预算影响分析(BIA)研究。
主要发现
- 最常评估的疫苗为肺炎球菌(41%)、流感(23%)和轮状病毒(18%)。
- 目标人群在21项研究(95%)中说明,研究视角在20项(91%)中明确。
- 仅36%报告完成BIA所用的计算,27%告知各时间段的总成本和分解成本,9%展示各时间段资源使用变化。
- 55%(n=12)的研究报告了清单中不足50%的推荐条目。
关键数值与推荐
- 目标人群说明:21项研究(95%)。
- 研究视角明确:20项研究(91%)。
- 报告BIA计算:36%的研究。
- 报告各时间段总成本和分解成本:27%的研究。
- 报告各时间段资源使用变化:9%的研究。
局限性
- 仅36%报告完成BIA所用的计算,27%告知各时间段的总成本和分解成本,9%展示各时间段资源使用变化。
- 超过半数研究(55%,n=12)报告了清单中不足50%的推荐条目,方法学步骤报告不理想,难以评估所呈现结果的有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Several countries require manufacturers to present a budget impact analysis (BIA), together with a cost-effectiveness analysis, to support national funding requests. However, guidelines for conducting BIA of vaccines are scarce. OBJECTIVES: To analyze the methodological approaches used in published budget impact analysis (BIA) of vaccines, discussing specific methodological issues related to vaccines. MATERIAL AND METHODS: This systematic review of the literature on BIA of vaccines was carried out in accordance with the Centre for Reviews and Dissemination - CRD guidelines. We searched multiple databases: MedLine, Embase, Biblioteca Virtual de Saúde (BVS), Cochrane Library, DARE Database, NHS Economic Evaluation Database (NHS EED), HTA Database (via Centre for Reviews and Dissemination - CRD), and grey literature. Two researchers, working independently, selected the studies and extracted the data. The methodology quality of individual studies was assessed using the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. A qualitative narrative synthesis was conducted. RESULTS: Twenty-two studies were reviewed. The most frequently evaluated vaccines were pneumococcal (41%), influenza (23%) and rotavirus (18%). The target population was stated in 21 studies (95%) and the perspective was clear in 20 (91%). Only 36% reported the calculations used to complete the BIA, 27% informed the total and disaggregated costs for each time period, and 9% showed the change in resource use for each time period. More than half of the studies (55%, n=12) reported less than 50% of the items recommended in the checklist. CONCLUSIONS: The production of BIA of vaccines has increased from 2009. The report of the methodological steps was unsatisfactory, making it difficult to assess the validity of the results presented. Vaccines specific issues should be discussed in international guidelines for BIA of vaccines, to improve the quality of the studies.
引用
- Loze PM, Nasciben LB, Sartori AMC, et al. Vaccines are different: A systematic review of budget impact analyses of vaccines. Vaccine. 2017. PMID: 28427846. doi:10.1016/j.vaccine.2017.03.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。